Clinical trial
Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic Epilepsy
NCT00216567 · Janssen Korea, Ltd., Korea, Industry · Completed
Key facts
| NCT number | NCT00216567 |
|---|---|
| Title | Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic Epilepsy |
| Official title | A Randomized, Open Label, Comparative, Multi-center Clinical Trial to Determine the Efficacy and Safety of Topiramate Comparing With Carbamazepine in Benign Rolandic Epilepsy. |
| Lead sponsor | Janssen Korea, Ltd., Korea, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Epilepsy, Rolandic |
| Intervention type | Drug |
| Interventions | topamax |
| Enrollment | 114 |
| Start date | Dec 1, 2002 |
| Completion | Feb 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Feb 1, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: